Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group

Vincenzo Arena, Luca Laurenti, Attilio Elio Giuseppe Crea, Marino Gentile, Robin Foa, Gian Matteo Rigolin, Francesco Cavazzini, Alfonso Piciocchi, Valentina Arena, Andrea Visentin, Gianluigi Reda, Giulia Zamprogna, Francesca Cibien, Orsola Vitagliano, Marta Coscia, Lucia Farina, Gianluca Gaidano, Roberta Murru, Marzia Varettoni, Rossella PaoliniPaolo Sportoletti, Daniela Pietrasanta, Anna Lia Molinari, Francesca M. Quaglia, Roberto Marasca, Monia Marchetti, Francesca R. Mauro, Enrico Crea, Marco Vignetti, Massimo Gentile, Marco Montillo, Robin Foà, Antonio Cuneo

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Fingerprint

Entra nei temi di ricerca di 'Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group'. Insieme formano una fingerprint unica.

Medicine & Life Sciences